Disclosures The faculty reported the following relevant financial - - PowerPoint PPT Presentation

disclosures
SMART_READER_LITE
LIVE PREVIEW

Disclosures The faculty reported the following relevant financial - - PowerPoint PPT Presentation

Disclosures The faculty reported the following relevant financial relationships during the content development process for this activity: Neha Yadav, MD Adhir R. Shroff, MD, FSCAI Nothing to disclose. Abiomed: Advisory Board, Speakers Bureau;


slide-1
SLIDE 1
slide-2
SLIDE 2

Disclosures

The faculty reported the following relevant financial relationships during the content development process for this activity: Adhir R. Shroff, MD, FSCAI Abiomed: Advisory Board, Speakers Bureau; Cardiovascular Systems, Inc.: Speakers Bureau; Medtronic: Speakers Bureau; Terumo: Speakers Bureau Mladen I. Vidovich, MD, FSCAI Boston Scientific: Principal Investigator; Merit Medical: Patent Holder/Intellectual Property Rights, Royalties Kusum Lata, MD, FSCAI Nothing to disclose. Manu Kaushik, MD Nothing to disclose.

Neha Yadav, MD Nothing to disclose. Katrine A. Zhiroff, MD, FACC, FSCAI Abiomed: Consulting; Novartis: Speakers Bureau; Terumo: Consulting CME Oversight Committee reviewer Anbukarasi Maran, MD, FSCAI, reported no financial relationships. SCAI staff associated with the development of content for this activity, Robert Bartel, MSc, FACEHP, and Laura Daigle Porter, CMP, reported no relevant financial relationships.

slide-3
SLIDE 3

Accreditation Statement

The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. SCAI designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

slide-4
SLIDE 4

Learning Objectives

  • Upon completion of this activity, participants will be able to:
  • Discuss strategies to incorporate transradial access into complex PCI (cPCI)

procedures

  • Review current data on outcomes of transradial cPCI as well as techniques to

improve procedural success

  • Describe the economic benefit and value of integrating transradial access into cPCI
  • Identify calcified lesions that may benefit from coronary atherectomy as an

adjunctive therapy to PCI

  • Understand optimal equipment and procedural set-up to perform coronary

atherectomy using transradial access

  • Identify patients at high risk of complications with coronary atherectomy
slide-5
SLIDE 5

Evaluation and Certificates

  • Evaluations are available through the SCAI 2019 app.
  • Please claim credit within 30 days of the meeting.
slide-6
SLIDE 6

Agenda

Moderator: Adhir R. Shroff, MD, FSCAI SCAI’s TRAnsition for VALUE and How It Applies to Complex PCI (cPCI) Adhir R. Shroff, MD, FSCAI Your TRA Support Network: How to Initiate Change Mladen I. Vidovich, MD, FSCAI SCAI’s Transradial Best Practices Statement – Update Kusum Lata, MD, FSCAI Case Presentation: TRA cPCI with Adjunctive Atherectomy Manu Kaushik, MD Mini-Debate

PCI with Atherectomy: Transfemoral Should Be the Default Access Site Neha Yadav, MD PCI with Atherectomy: Transradial Should Be the Default Access Site Katrine A. Zhiroff, MD, FACC, FSCAI